Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Not Yet Recruiting NCT05643508

A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and Hyperlipidemia

Conditions: Hypertension, Hyperlipidemias

Sex: All

Ages: 19 Years – 80 Years

Phase: PHASE3

Enrollment: 192

Sponsor: Daewoong Pharmaceutical Co. LTD.

Summary

This study aims to evaluate the efficacy and safety of co-administration of DWC202206 and DWC202207 in patients with concomitant hypertension and hyperlipidemia.

Eligibility Criteria

Inclusion Criteria:Age 19 to 80 yearsPatients with hypertension and hyperlipidemiasExclusion Criteria:Orthostatic hypotensionHistory of ventricular tachycardia, atrial fibrillationUncontrolled diabetes mellitus

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05643508). StuddyBuddy aggregates publicly available trial information.